financetom
Business
financetom
/
Business
/
Niobay Metals Confirms Extension of Mineralization on Its Crevier Project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Niobay Metals Confirms Extension of Mineralization on Its Crevier Project
Sep 11, 2025 10:13 AM

12:48 PM EDT, 09/11/2025 (MT Newswires) -- Niobay Metals ( NBYCF ) on Thursday confirmed the extension of mineralization on its Crevier niobium and tantalum project in Quebec and intersected rare earth elements in its northernmost holes.

The company completed its 2025 drilling program in August, with assays on eight of 15 holes showing rare-earths content.

Niobay said the results will be added to the historical information and will be used to update a resource estimate. It added that it could now observe the presence of mineralization over more than 6 kilometers.

Niobay said this campaign will allow the recovery of mineralized material in order to conduct a second pilot test, which is expected to represent "more than 10 times the volume of the first pilot test.". For Crevier, the company still needs to collect a bulk sample in early fall.

"We also intercepted rare earths mineralization in our northernmost drill holes, with a marked presence of strontium," said Chief Executive Jean-Sebastien David. "The new resource estimate will allow us to better qualify the drill results obtained."

The company added that Crevier will be exclusively dedicated to the production of niobium oxide for battery manufacturers, following the completion of studies indicating positive parameters for this project.

Shares of the company were last seen up $0.005 to $0.08 on the TSX Venture Exchange.

Price: 0.08, Change: +0.01, Percent Change: +6.67

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Freeport LNG in Texas to restart one train this week after Hurricane Beryl
Freeport LNG in Texas to restart one train this week after Hurricane Beryl
Jul 15, 2024
NEW YORK/HOUSTON, July 15 (Reuters) - Freeport LNG plans to restart one of three liquefied natural gas trains this week at its Texas facility after the company repairs some damage from Hurricane Beryl, it said on Monday. The plant, in Freeport, Texas, south of Houston, halted operations on July 7 before Beryl hit the coast, causing widespread power outages and...
BlackRock Sees 'Great Potential' to Monetize Power Production Capacity of Infrastructure Assets Amid AI Boom
BlackRock Sees 'Great Potential' to Monetize Power Production Capacity of Infrastructure Assets Amid AI Boom
Jul 15, 2024
02:10 PM EDT, 07/15/2024 (MT Newswires) -- BlackRock ( BLK ) on Monday touted the potential to monetize the power production capacity of assets owned by its infrastructure funds amid growing artificial intelligence adoption. Data centers associated with AI will need enormous amounts of energy to power them, Chief Executive Laurence Fink said on an earnings conference call, according to...
Bristol-Myers Squibb Unusual Options Activity For July 15
Bristol-Myers Squibb Unusual Options Activity For July 15
Jul 15, 2024
Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb ( BMY ). Our analysis of options history for Bristol-Myers Squibb ( BMY ) revealed 10 unusual trades. Delving into the details, we found 30% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $136,531,...
Vertex sues US over fertility support program for Casgevy gene editing therapy
Vertex sues US over fertility support program for Casgevy gene editing therapy
Jul 15, 2024
July 15 (Reuters) - Vertex Pharmaceuticals ( VRTX ) sued the U.S. Department of Health and Human Services on Monday, seeking a court declaration that a fertility support program for patients who are prescribed its gene editing therapy Casgevy does not violate federal anti-kickback laws. Casgevy is approved for the treatment of two genetic disorders - sickle cell disease and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved